BofA raised the firm’s price target on MetLife (MET) to $104 from $100 and keeps a Buy rating on the shares. The firm is updating its price targets for U.S. Insurance companies under its coverage, the analyst tells investors. Q3 turned out to be a “relatively calm” season without any hurricanes making landfall in the U.S. and, while 1H saw elevated levels of macro uncertainties, this did not translate to material adverse impact on earnings, the firm says.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target raised to $98 from $93 at Barclays
- MetLife price target raised to $97 from $94 at Morgan Stanley
- MetLife Announces Preliminary Q3 2025 Investment Income
- Intel downgraded, Tesla upgraded: Wall Street’s top analyst calls
- MetLife downgraded to Neutral from Overweight at Piper Sandler